Skip to content
Home/Companies/Biotech/InBrain Pharma
IP

InBrain Pharma

Biotech·France·Active

INBRAIN PHARMA is a healthcare company, headquartered in France.

Entry
–
Hold
–
Status
Active
Est. EV
–

Who owns InBrain Pharma?

InBrain Pharma is currently owned by Finovam Gestion through FIRA (2015 vintage).

Hand-verified · updated 2026-04-21

Finovam Gestion
Investor
Finovam Gestion
FIRA · 2015 · VC

Key facts

HQFrance
SectorHealthcare

More from FIRA

Other portfolio companies in the same fund.

Lattice Medical
Active
MedTechFrance
Innobiochips
Active
HealthcareFrance· 2023
Nolej
Active
EdTechFrance· 2023
Apmonia Therapeutics
Active
HealthcareFrance· 2022
Augmenteo
Active
GamingFrance· 2020
Whispeak
Active
SoftwareFrance· 2020

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Adcendo
Active
Jeito CapitalDenmark· 2026
Data refreshed weekly · Sourced from public filings